Neurocrine Biosciences (NBIX) Net Income

Price: $102.88
Market Cap: $10.26B
Avg Volume: 1.33M
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.353
52W Range: $102.55-157.98
Website: Neurocrine Biosciences

What is Neurocrine Biosciences's Net Income?

  • Neurocrine Biosciences's annual net income as of FY 2024 is $341.30M.
  • Neurocrine Biosciences's quarterly net income as of Q4 2024 is $103.10M.

What is Net Income?

Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.

Related Metrics

Other important metrics to assess Neurocrine Biosciences's financial health include:

  • Net Income Growth - the rate at which a company's net income is growing:
    • Annual Growth: 36.68%
  • Net Income Ratio - net income divided by revenue:
    • Annual: 14.49%
    • Quarterly: 16.43%
  • Net Income Per Share - net income divided by the number of shares outstanding:
    • Annual: $3.40

These metrics provide insights into Neurocrine Biosciences's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Net Income

$341.30M

Quarterly Net Income

$103.10M

Historical Annual Net Income
$500.00M$500.00M$400.00M$400.00M$300.00M$300.00M$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00MNet Income (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Net Income
$400.00M$400.00M$300.00M$300.00M$200.00M$200.00M$100.00M$100.00M$0.00$0.00-$100.00M-$100.00M-$200.00M-$200.00MNet Income (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Annual Net Income Growth
1200.00%1200.00%900.00%900.00%600.00%600.00%300.00%300.00%0.00%0.00%-300.00%-300.00%Net Income Growth (%)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Annual Net Income Per Share
$6.00$6.00$4.00$4.00$2.00$2.00$0.00$0.00$-2.00$-2.00Net Income Per Share20162016201720172018201820192019202020202021202120222022202320232024202420252025

Neurocrine Biosciences Historical Net Income Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Net Income Net Income Growth Net Income Ratio Net Income Per Share
2024 $341.30M 36.68% 14.49% $3.40
2023 $249.70M 61.62% 13.23% $2.56
2022 $154.50M 72.43% 10.38% $1.61
2021 $89.60M -78.00% 7.90% $0.95
2020 $407.30M 1000.81% 38.94% $4.37
2019 $37.00M 75.26% 4.69% $0.40
2018 $21.11M 114.81% 4.68% $0.22
2017 $-142.54M -1.03% -88.19% $-1.62
2016 $-141.09M -58.65% -940.60% $-1.63
2015 $-88.93M -46.89% -449.84% $-1.05